MAIA Share Price Performance
US$0
-2.13 (-100.00%)
Price US$0
Share Pricen/a
MAIA Biotechnology, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
MAIA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
MAIA Biotechnology, Inc. Key Details
About MAIA
- Founded
- 2018
- Employees
- 13
- CEO
- WebsiteView website
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
